Objective: Recent evidence suggests that high cortisol concentrations are associated with increased morbidity and mortality in very low birth weight (VLBW) infants. Neonatal illness severity and mortality risk scores are reliable in predicting morbidity and mortality. The objectives were (i) to assess the correlation between serum cortisol levels and clinical assessment of multi-organ dysfunction/illness severity scores (CRIB II, SNAPPE-II and neonatal multiple organ dysfunction score (NEOMOD)) in first 24 h in VLBW infants and (ii) to assess the relationship between surrogates of end organ blood flow and serum cortisol levels.
Introduction
The immediate postnatal period in very low birth weight (VLBW) infants is frequently complicated by hypotension and low end-organ flow. Superior vena cava (SVC) flow has proven to be a useful marker of systemic blood flow, 1 but is not easily obtained at the bedside. Blood pressure values are readily available at the bedside and hypotension has been associated with adverse short-term and long-term outcome. 2, 3 A number recent studies have focused on evaluating the role of hydrocortisone therapy in hypotension and suspected adrenocortical insufficiency in the sick preterm infants during the early course of life. [4] [5] [6] Corticosteroids have been previously utilized for the prevention and treatment of chronic lung disease. 7 However, hydrocortisone is now more widely prescribed to treat hypotension than chronic lung disease in preterm neonates. 8 More recent evidence suggests that high cortisol concentrations may be associated with increased morbidity and mortality in extremely low birth weight infants and low cortisol levels do not seem to predict adverse short-term outcomes. 9 A number of illness severity scores have been developed for the preterm infant. Illness severity and mortality risk scores for neonatal intensive care represent reliable means capable of predicting morbidity and mortality in VLBW neonates. [10] [11] [12] [13] [14] [15] Illness severity scores for newborns are complex systems with validations and calibrations restricted by birth weight. CRIB II provides a recalibrated and simplified scoring system aiming to avoid the potential problems of early treatment bias. 13 SNAPPE-II is a simple, empirically validated illness severity and mortality risk score. 14 Neonatal multiple organ dysfunction score (NEOMOD) evaluates daily severity of multiple organ dysfunction and is the only neonatal organ dysfunction score published. 16 It has been proven to be an accurate predictor of mortality. 17 Several authors have previously evaluated the relationship between SVC blood flow measurements and mean blood pressure in a cohort of VLBW infants with various results. [18] [19] [20] In this prospective study our objectives were to evaluate the relationship between serum cortisol values and markers of cardiovascular status (SVC flow and blood pressure) as well as between cortisol values and the three aforementioned illness severity scores in VLBW infants during the first 24 h.
Methods
We carried out a prospective observational cohort study in a level III neonatal intensive care unit in Coombe Women and Infants University Hospital between November 2006 and June 2007. Patients were included if they were VLBW (<1500 g), admitted to the neonatal intensive care unit on the first day of life and parental consent was obtained. Newborns with congenital heart disease (except patent ductus arteriosus), major congenital malformations or newborns receiving hydrocortisone before echocardiography were excluded. The institutional research ethics committee approved this study.
Echocardiography
All infants, where consent was obtained, had an echocardiography examination performed on day 1, between 12 and 24 h of age independent of clinical status of the baby. The exact timing of the ultrasound was dependent on the investigator availability. We used Philips HD11XE ultrasound scanner with curved array transducer (5 to 8 MHz) incorporating color flow and pulse-wave Doppler with adaptive Doppler technology. The scan was recorded on the hard disk of the ultrasound machine and measurements were carried out at a later stage. Structural normality of the heart was established and the SVC flow measurement was taken using protocol described previously. 18 SVC flow was expressed as ml kg À1 min À1 . The echocardiography measurements were carried out by the same person on each occasion to limit the inter-investigator variation that may occur.
Clinical and physiological data
Blood pressure (systolic, diastolic and mean) either invasive (peripheral or umbilical artery) or non-invasive (pressure cuffFCritikon soft-cuff sizes 1 to 4) and blood pressure support were recorded at the time of the scan. Cortisol concentrations were measured at the time of the ultrasound examination by Immulite 2000 cortisol assay (Siemens Healthcare Diagnostics, Deerfield, IL, USA).
Clinical scoresFCRIB II, SNAPPE II and NEOMODFwere calculated as appropriate. Hypotension was treated based on a combination of clinical and biochemical parameters and clinicians were blinded to echocardiography flow assessment. Hydrocortisone was added if there was no response to volume and inotrope administration. Patients receiving hydrocortisone before echocardiography were excluded from our study. Data were analyzed with a PC-based statistics package (StatsDirect version 2.6.1) using Fisher's exact test, Mann-Whitney U-test and non-parametric linear regression. P<0.05 was accepted as significant.
Results
There were 54 VLBW neonates admitted and all were enrolled following parental consent between November 2006 and June 2007. Two patients were subsequently excluded because of congenital malformations (one patient with Down's syndrome, a second patient with a large perimembranous ventricular septal defect) and in 12 infants serum cortisol concentration was not obtained for various reasons (no invasive line, insufficient sampling). Two patients received therapeutic hydrocortisone before the echocardiography and were excluded. Therefore 38 patients were included in the study. The characteristics of the study cohort are presented in Table 1 . The mean (s.d.) birth weight was 1.08 (0.3) kg, mean gestational age was 27.8 (1.9) weeks gestation and the mean hour of life at echocardiography/ cortisol evaluation was 18.5 (5.5) h. The mean (s.d.) cortisol level was 544.3 nmol l À1 (627.9) and SVC flow 75.9 ml kg À1 min
À1
(35.7). Median (range) CRIB II, SNAPPE II and NEOMOD scores for the cohort were 7 (3-15), 16 (0-80) and 2 (1-8), respectively. In total, 6 infants received volumotherapy as initial treatment of hypotension before echocardiography, 4 of these infants received also inotropic support. There was no statistically significant difference between cortisol levels of the group with and without inotropic support (mean 699 vs 507 nmol l À1 , P ¼ 0.58). There was no correlation between serum cortisol concentrations and SVC flow (P ¼ 0.49) (Figure 1 ) or between serum cortisol values and mean blood pressure values (P ¼ 0.35) (Figure 2) .
High cortisol values correlated significantly with NEOMOD score (P ¼ 0.006) (Figure 3 ) and weakly with SNAPPE II score (P ¼ 0.11) (Figure 4 ). There was no relationship between cortisol and CRIB II score (P ¼ 0.34).
Discussion
The immediate postnatal period in the VLBW infant is often complicated by systemic hypoperfusion resulting in significant 
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Serum cortisol values and illness severity J Miletin et al neonatal morbidity, including intraventricular hemorrhage and death. Our ability to diagnose low end-organ flow states has been primarily based on measuring mean blood pressure values in conjunction with clinical signs of hypoperfusion. Typically intervention includes volume and dopamine followed by corticosteroid administration. 21 The rationale behind the use of corticosteroids is suspected adrenocortical insufficiency 22 manifest predominantly by systemic hypotension. 5 Arnold et al 23 identified a significant positive correlation between serum cortisol values and blood pressure. A number of studies evaluating cortisol concentrations in the preterm infant have identified an association between low cortisol levels and adverse outcomes, including inotrope use 24 and chronic lung disease. 25 Ng et al 24 identified an inverse relationship between day 7 cortisol concentrations and the maximal dose of vasopressor therapy administered. There are a number of prospective randomized trials addressing the efficacy of corticosteroid use for both the prevention and treatment of hypotension. [26] [27] [28] [29] [30] In one of the prophylactic studies a reduction in inotrope use was noted, 29 but no difference in inotrope use in the second. 30 There was a clinically significant increase in the number of adverse effects including hyperglycemia necessitating insulin infusion and gastric perforation in the treated group. 29 In the treatment trials there was variation with respect to increase in blood pressure and reduction in inotrope use. No advantage of steroids has been documented for any clinically relevant outcomes (death or intraventricular haemorrhage rate) and no long-term outcome data are provided in any of the trials. Serum cortisol values and illness severity J Miletin et al
We did not identify any association between serum cortisol concentrations and mean blood pressure values nor were we able to identify any relationship between serum cortisol and echocardigraphic assessment of SVC blood flow. This finding, albeit in a small cohort of patients, is not surprising considering the conflicting evidence that exists concerning cortisol concentrations. It would seem that serum cortisol is a very poor indicator overall of cardiovascular status. We did identify a strong correlation between the NEOMOD scoring system and serum cortisol levels, a finding consistent with the findings of a recent secondary analysis of the Prophet Study. Aucott et al 9 showed that extremely high cortisol values were associated with increased morbidity and mortality rates, high cortisol levels were associated with severe intraventricular hemorrhage and low cortisol concentrations were not predictive of adverse short-term outcomes in an analysis of 360 extremely preterm infants. It seems that sick preterm infants are capable of producing elevated concentrations of cortisol and that cortisol is more a marker of stress rather than any useful marker of systemic perfusion.
There was a strong correlation between NEOMOD score and cortisol levels. SNAPPE II was associated with a weak correlation and there was no correlation between CRIB II and cortisol levels. It is not surprising as NEOMOD evaluates dysfunction of seven main 'organ' systems (central nervous system, coagulation, respiratory, gastrointestinal, cardiovascular, renal system and acid-base balance) in 24-h intervals. It can be used in the first 28 days of life to predict the mortality in VLBW infants and it is the only neonatal organ dysfunction score described. CRIB II and SNAPPE II were designed to predict mortality of infants admitted to the neonatal intensive care unit in the first 24-h of life. CRIB II score includes gender, gestation, birth weight, admission temperature and base deficit, and may not accurately reflect immediate clinical status. SNAPPE II score includes a number of variables (mean arterial blood pressure, temperature, oxygenation, serum pH, seizure activity, urine output, Apgar's scores, birth weight and small for gestational age assessment) and may better reflect immediate clinical status compared with CRIB II.
There are some limitations to this study. The overall number of patients enrolled was small. Although 95% received antenatal corticosteroids the exact timing of the second dose before delivery was not available. This may interfere with the serum cortisol value obtained. Another concern is the fact that we measured serum cortisol values, rather than urinary free cortisol values which may be a better measure of overall adrenal status.
The decision to administer hydrocortisone therapy for the treatment of low systemic blood pressure remains questionable. It would seem from this and the larger Alcutt study that assessment of serum cortisol values in an attempt to identify truly adrenal insufficient patients adds little to the therapeutic algorithm for the management of suspected adrenal insufficiency and hypotension in the VLBW infant. In fact the corollary may be true, patients with elevated serum cortisol levels are the sickest and may benefit most from the administration of corticosteroids.
We showed no correlation between SVC flow and cortisol concentration or between cortisol and mean blood pressure values in a cohort of VLBW infants. We identified a significant correlation between serum cortisol values and NEOMOD suggesting that sick, stressed VLBW infants do mount a stress response.
